MetLife, Inc. operates as a leading global financial services entity, delivering an extensive array of services encompassing insurance, annuities, employee benefits, and asset management. The company manages its operations through five primary divisions: the U.S., Asia, Latin America, Europe, the Middle East and Africa…
An institutional-grade, numbers-driven thesis on MET — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of August 8, 2026, TradersQuant's model rates MetLife, Inc. (MET) 64/100 with a 12-month base-case forecast of $98.56 — +0.8% versus the current price of $97.77. MetLife, Inc. trades at $97.77 in the Financial Services sector, with a market capitalisation of $62.91B. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month analyst consensus price target for MET is $98.56, implying +0.8% versus the current price. The model's 12-month scenario range runs from $101.87 (bear) to $129.85 (bull), with a base case of $111.24.
On the fundamentals, MetLife shows a P/E of 18.7, trailing revenue of $77.08B, revenue growth of +10.2% YoY, a dividend yield of 2.37%. This page also tracks MET's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
MET currently carries a TradersQuant composite score of 64/100, which we read as a neutral-to-watch signal. The Wall-Street analyst consensus is "Buy". Our 12-month price target of $98.56 implies +0.8% from $97.77. This is research, not financial advice — always combine it with your own judgement.
The analyst consensus price target for MET is $98.56, about +0.8% versus the latest price of $97.77. Consensus is based on 33 analysts.
TradersQuant's 12-month model forecast for MET is a base case of $111.24, ranging from $101.87 (bear) to $129.85 (bull), an expected return of +13.8%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for MET over the next 12 months is $111.24 in the base case (bear $101.87, bull $129.85), versus today's price of $97.77. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for MET — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates MET's fair value at $98.56, implying +0.8% of expected upside versus the current price.
Yes — MetLife pays a dividend yielding 2.37% (about $2.32 per share annually).
Data and model outputs are for research only and are not financial advice. Figures update continuously.
